Stifel reiterated coverage on ALX Oncology Holdings with a new price target
$ALXO
Biotechnology: Pharmaceutical Preparations
Health Care
Stifel reiterated coverage of ALX Oncology Holdings with a rating of Buy and set a new price target of $36.00 from $60.00 previously